Scientific and technological services featuring testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching; scientific and technological services featuring pharmacogenomic testing analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of analyzing how an individual's cultural and environmental factors affect their response to drugs, improve drug selection and dosage recommendations, select initial and subsequent medications, identify drug-drug interactions, avoid adverse drug reactions, develop clinical treatment decision support recommendations, and support other medical diagnostic products and prescription drugs; determining a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; determining a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors, together with genetic variants, epigenetic factors and multiomics to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services featuring testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of supporting drug clinical trials, and research into the field of new drug development and drug repurposing; scientific and technological services featuring testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions, including stress resulting from adverse conditions; age-related health; isolation or cognitive circumstances; behavior harmful to self or others; childhood and/or adolescent neglect and abuse; adult trauma associated with events, including sexual, physical and psychological abuse; acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths; stress; trauma; abuse; poverty; food insecurity and hunger; imprisonment; interpersonal conflict; violence; presence or absence of parents, children, siblings, and other family members and acquaintances; gender; ancestry; transgenerational social factors; age; income; marital status; education level; language; other household data; cultural situations; circadian data; ethnicity-related health; community living conditions; biological sex; ethnicity; and other non-genetic factors; scientific and technological services featuring testing, analysis and evaluation to determine a patient's medication and drug response associated with cultural and environmental factors, including stress resulting from adverse conditions; age-related health; isolation or cognitive circumstances; behavior harmful to self or others; childhood and/or adolescent neglect and abuse; adult trauma associated with events, including sexual, physical and psychological abuse; acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths; stress; trauma; abuse; poverty; food insecurity and hunger; imprisonment; interpersonal conflict; violence; presence or absence of parents, children, siblings, and other family members and acquaintances; gender; ancestry; transgenerational social factors; age; income; marital status; education level; language; other household data; cultural situations; circadian data; ethnicity-related health; community living conditions; biological sex; ethnicity; and other non-genetic factors; scientific and technological services featuring testing, analysis and evaluation of one's periodic changes in response to medical treatment, pharmacological adverse reactions, drug-drug interactions, drug dosing changes, and new or recurring comorbidities